Phase II trial of cisplatin, interferon alpha-2b, doxorubicin, and 5-fluorouracil for biliary tract cancer. [electronic resource]
Producer: 20020221Description: 3375-80 p. digitalISSN:- 1078-0432
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Biliary Tract Neoplasms -- drug therapy
- Cisplatin -- administration & dosage
- Diarrhea -- chemically induced
- Dose-Response Relationship, Drug
- Doxorubicin -- administration & dosage
- Fatigue -- chemically induced
- Female
- Fluorouracil -- administration & dosage
- Hematologic Diseases -- chemically induced
- Humans
- Infusions, Intravenous
- Injections, Subcutaneous
- Interferon alpha-2
- Interferon-alpha -- administration & dosage
- Male
- Middle Aged
- Nausea -- chemically induced
- Recombinant Proteins
- Survival Analysis
- Treatment Outcome
- Vomiting -- chemically induced
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.